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Background: Plantar calluses are a common cause of foot pain, which can have a detrimental impact on the
mobility and independence of older people. Scalpel debridement is often the first treatment used for this
condition. Our aim was to evaluate the effectiveness of scalpel debridement of painful plantar calluses in older
people.
Methods: This study was a parallel-group, participant- and assessor-blinded randomized trial. Eighty participants
aged 65 years and older with painful forefoot plantar calluses were recruited. Participants were randomly allocated
to one of two groups: either real or sham scalpel debridement. Participants were followed for six weeks after their
initial intervention appointment. The primary outcomes measured were the difference between groups in pain
(measured on a 100-mm visual analogue scale) immediately post-intervention, and at one, three and six weeks
post-intervention.
Results: Both the real debridement and sham debridement groups experienced a reduction in pain when
compared with baseline. Small, systematic between-group differences in pain scores were found at each time point
(between 2 and 7 mm favoring real scalpel debridement); however, none of these were statistically significant and
none reached a level that could be considered clinically worthwhile. Scalpel debridement caused no adverse
events.
Conclusions: The benefits of real scalpel debridement for reducing pain associated with forefoot plantar calluses in
older people are small and not statistically significant compared with sham scalpel debridement. When used alone,
scalpel debridement has a limited effect in the short term, although it is relatively inexpensive and causes few
complications. However, these findings do not preclude the possibility of cumulative benefits over a longer time
period or additive effects when combined with other interventions.
Trial registration: Australian Clinical Trials Registry (ACTRN012606000176561).
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Calluses are hyperkeratotic skin lesions that commonly
develop on the plantar surface of the forefoot in re-
sponse to mechanical stress [1]. These lesions are highly
prevalent in older people, with estimates ranging from
36% to 78% in community-dwelling older populations
[2-9]. Calluses are a common cause of foot pain [3],
which can have a significant, detrimental impact on the
mobility and independence of an older person [10]. Foot
pain in older people has been associated with functional
limitation, disability in activities of daily living and an in-
creased risk of falling [3,11-15]. Therefore, appropriate
management of painful corns and calluses in older
people is important for maintaining functional status.
Scalpel debridement is often the first treatment used for
providing temporary pain relief of symptomatic calluses
[16-18].
Currently, evidence from rigorous randomized trials
evaluating the effectiveness of scalpel debridement for
painful plantar calluses in otherwise healthy older people
does not exist. To date, the clinical decision to debride
these symptomatic lesions has been based largely on an-
ecdotal evidence and non-randomized trials [19-21].
Therefore, the aim of this study was to evaluate the ef-
fectiveness of scalpel debridement of painful plantar cal-
luses in older people.
Methods
Design overview
We conducted a parallel-group, participant- and assessor-
blinded randomized trial. Recruitment occurred from May
2006 to November 2008. Participants were randomly allo-
cated to receive one of two treatments: either real callus
debridement, or sham callus debridement. Ethical ap-
proval for the trial was gained from the Faculty Human
Ethics Committee at La Trobe University (Application
number FHEC06/25). All participants provided written in-
formed consent prior to recruitment.
Setting and participants
Participants were recruited from patients at the La
Trobe University Podiatry Clinic and from residents at
the La Trobe Retirement Village, Bundoora, Australia.
Participants were included in the trial if they were aged
65 years or older and had a painful plantar forefoot
callus that had not been treated in the previous six
weeks. Pain at the callus site needed to register at least
20 mm on a 100-mm visual analogue scale. Participants
were excluded from the trial if they had any inflamma-
tory or neurological condition that affected the feet, or if
they had received foot orthoses in the previous two
months, or were expecting to receive an in-shoe device
during the six-week intervention period, or if they had a
history of plantar forefoot ulceration in the previousthree months, or if they had had a foot amputation that
was proximal to the digits. Participants were also
deemed ineligible if they were unable to walk household
distances without an aid or were cognitively impaired
(defined as a score of <7 on the Short Portable Mental
Status Questionnaire [22]).
Clinical protocol
Participants were assessed and treated at the La Trobe
University Podiatry Clinic. The intervention was
performed in a clinical treatment room, which was sep-
arate from the research room, where data collection was
conducted. The random allocation sequence was gener-
ated in one block of 100 (50 experimental, 50 control)
under the knowledge that we would recruit fewer partic-
ipants than this; see section entitled ‘Sample size and
statistical analysis’. The allocations were concealed from
the investigators enrolling participants in sequentially
numbered opaque, sealed envelopes – this system has
been previously reported [23] and has been recommended
by the CONSORT Statement [24] as an alternative to
third-party systems. The envelope that corresponded to
the participant’s study number was only opened (by the
clinician providing the intervention) after the enrolled par-
ticipant completed all baseline assessments and received
any initial treatment (such as nail cutting). This
corresponded to the time that the study intervention for
the plantar forefoot needed to be allocated.
Intervention
Following baseline assessments, which were conducted
in the research room, all participants were escorted to
the clinical treatment room, where they initially received
treatment of nails and hyperkeratotic lesions other than
those on the plantar surface of the metatarsal heads (for
example, dorsal digital lesions). Once this treatment was
completed, a curtain was drawn between the clinician
providing the intervention and the participant, to pre-
vent the participant from viewing the intervention for
the plantar forefoot callus. From this moment, the clin-
ician providing the intervention did not communicate
with the participant. A second investigator conducting
the assessment (who remained blinded to the interven-
tion) sat next to and continued to communicate with
the participant.
The ‘experimental’ intervention involved real (sharp)
scalpel debridement of all plantar forefoot callus or
corns on both feet. By contrast, the ‘control’ intervention
involved sham debridement, where the scalpel blade was
positioned upside down and the blunt edge of the blade
was scraped over the surface of the callus with no re-
moval of the lesion. We attempted to control the time
taken for ‘debridement’ in the control group by spending
an appropriate time for the size and thickness of the
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tended time for a large, thick callus). To further mimic
normal treatment, a fine paper-sanding disc (Moore’s
disc) was used very lightly on the entire plantar forefoot
callus in both groups. To maintain blinding while trans-
ferring participants back to the research room for data
collection, a thin gauze tape (Mefix®) was applied over
the plantar callus site and surgical booties placed over
both feet, which were removed just prior to the immedi-
ate post-intervention outcome evaluation.
Following evaluation, the thin gauze tape was re-
moved, then tincture of benzoin compound (Friar’s Bal-
sam) and a moleskin pad was applied to both plantar
forefeet, as is often done in usual care. To ensure
blinding, participants were not allowed to view the plan-
tar surface of their feet during this time. All participants
(that is, both groups) received the moleskin pad and par-
ticipants were advised to leave the pads on for at least
two days. A follow-up appointment was arranged for
outcome measurement to be repeated after six weeks.
Outcomes and follow-up
To measure the pain at the most painful callus site, a
100-mm visual analogue scale was used. Participants
were required to nominate the most painful callus site
on the plantar aspect of their forefeet and they were
asked to concentrate on that site when completing all
outcome measures. Measurements of pain were obtained
pre- and immediately post-intervention, and on a weekly
basis thereafter for six weeks. Pain measurements at the
initial appointment (pre- and immediately post-
intervention) and follow-up appointment (six weeks
post-intervention) were recorded under the supervision
of the investigator conducting the assessments, who was
blinded to the intervention. Five visual analogue scales
were given to each participant at the conclusion of the
initial appointment, for recording pain levels at home in
weeks one through five post-intervention.
To measure plantar pressure, the MatScan® system
(Tekscan, Boston, MA), recording at a sampling rate of
40 Hz was used. Tekscan’s sensor technology has been
shown to be valid and reliable for plantar pressure meas-
urement [25,26]. The method of data collection was
similar to previous studies we have conducted [25,27].
The mat was calibrated for each participant using each
participant’s own bodyweight prior to testing, and a two-
step gait initiation protocol was used [28-30]. Three tri-
als were recorded [28,29], and any abnormal or aberrant
footprints were discarded until three representative foot-
prints had been recorded. As walking speed can affect
plantar pressure [31], each trial was timed to ensure
each participant walked at a consistent speed for each of
their pressure trials. Following data collection, Research
Foot® software (version 5.24) was used to constructparticipant-specific ‘masks’ to determine peak plantar
pressure (kg/cm2) under the most painful callus site, as
specified by the participant.
To measure physical performance, a series of four bal-
ance and functional ability tests were conducted, includ-
ing maximum balance range [32], a timed sit-to-stand
test, an alternate step test, and a timed six metre walking
test (that is, walking speed) [33]. These tests have been
previously used to assess the effect of foot problems on
balance and functional ability in older people [34]. All
tests were performed without shoes to eliminate foot-
wear as a variable, and maximum balance range and
walking speed were normalized for height prior to
analysis.
Sample size and statistical analysis
The sample size of 80 (that is, 40 per group) was deter-
mined before beginning the trial. This sample size pro-
vided an 80% probability of detecting a clinically
worthwhile difference between the interventions of 13
mm (standard deviation (SD), 20 mm) on a visual
analogue scale for pain (α = 0.05), which was the pri-
mary outcome measure. This estimate for the sample
size also factored in a 5% drop-out rate and conserva-
tively ignored the extra precision provided by the covari-
ate analysis we employed.
All data were analyzed by intention to treat and
according to a pre-planned protocol as outlined in our
clinical trial registration. For all missing data, each par-
ticipant’s previous score was carried forward (that is, the
last observation was carried forward). Continuous data
were initially checked to ensure they did not deviate
from the assumption of a normal distribution – all vari-
ables were normally distributed. To maximize precision
of estimates, analysis of covariance (ANCOVA) was
conducted using a linear regression approach [35]. The
primary outcomes analyzed were the difference between
groups in pain immediately post-intervention, and at
one, three and six weeks post-intervention (making four
time-points in all). All other measured variables were
considered secondary outcomes.
To avoid bias in selecting covariates, we pre-specified
that the baseline outcome measure would be used as the
only covariate in each analysis [36]. For example, when
comparing pain at each time point, adjustments were
made for pain at baseline. The primary aim was to esti-
mate the magnitude of effects, but hypothesis tests were
also conducted. Mean differences, 95% confidence inter-
vals and P values were calculated, and hypothesis tests
were considered significant for P < 0.05.
An independent sample t test was used to determine
whether there were differences between groups for time
to follow-up and time spent debriding the painful plan-
tar callus. A one-way between-group analysis of variance
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speed between the real debridement and sham debride-
ment groups at the three time-points that plantar pres-
sure was measured.
Results
Participants in this trial had a mean age of 72.5 years
(SD, ±5.5); they were primarily female (63% of the sam-
ple) and presented with relatively high levels of pain at
the callus site (mean 51 mm, SD, ±21), which was most
often beneath the second metatarsal head. Table 1 pro-
vides the baseline characteristics of participants. Partici-
pants in the two groups had similar characteristics at
baseline, although the real debridement group had
slightly higher pain levels at baseline (54.6 mm vs. 47.9
mm); our ANCOVA statistical model adjusted for this.
The progression of participants through the trial is
presented in Figure 1. Two participants (one participant
in each group) were lost to follow-up over the six-week
period. One participant also failed to return visual
analogue scales for weeks one to five post-intervention.
Accordingly, we had very little missing data that re-
quired imputation as per the intention-to-treat protocol
that we observed.
There was no statistically significant difference be-
tween the groups in the time to follow-up (t78 = 0.237,
P = 0.813). However, there was a statistically significant
difference between the groups in the time taken to de-
bride (normal versus sham debridement) the entire plan-
tar forefoot callus of both feet (t78 = 2.439, P = 0.017).Table 1 Baseline characteristics of participants




n = 41 n = 39
Age, years 71.8 (5.5) 73.3 (5.4)
Number of women (%) 30 (73%) 20 (51%)
Weight, kg 74.4 (13.4) 79.6 (14.8)
Height, m 1.64 (0.08) 1.66 (0.11)
Body mass index, kg/m2 27.9 (4.7) 29.2 (4.1)
Heel height of shoe, mm 15.1 (6.5) 14.1 (6.8)
Hallux valgus, measured using the
Manchester Scale [37]
1 (0 to 3) 1 (0 to 3)
Median toe deformities (range) 1 (1 to 2) 1 (1 to 2)
Pain at callus site, mm on a visual
analogue scale
54.6 (21.0) 47.9 (20.8)
Peak plantar pressure, kg/cm2 2.15 (0.48) 2.39 (0.42)
Maximum balance range, cm 12.0 (4.1) 11.1(2.8)
Sit-to-stand time, s 14.2 (4.6) 14.5 (4.6)
Alternate step time, s 13.7 (4.4) 13.5 (3.8)
6-m walking time, s 6.1 (1.6) 6.7 (1.6)
Values are means (SD), unless stated otherwise.The mean time for normal debridement of the plantar
callus in the experimental group was 13.9 minutes (SD
±5.5) compared with the mean time of 11.0 minutes (SD
±5.1) for sham debridement in the control group.
Primary outcomes
Compared with baseline, both groups experienced improve-
ments in pain immediately post-intervention, and at one
and three weeks post-intervention (Table 2). When com-
paring raw pain levels following intervention, the real de-
bridement group had lower mean pain scores than the
sham debridement group, except at weeks five and six post-
intervention, where pain scores were essentially the same
(Figure 2). Evaluation of Figure 2 indicates a small, system-
atic difference in pain scores between the two groups from
immediately post-debridement through weeks one to four.
However, there were no statistically significant differences
at any time point (Table 2). The largest mean difference be-
tween the groups, at one week post-intervention, was −7.2
mm (favoring the real debridement group).
Secondary outcomes
Like the primary pain outcomes, the mean pain scores for
both groups at two, four and five weeks post-intervention
were less than the baseline scores (Figure 2). The real de-
bridement group had lower mean pain scores than the
sham debridement group at two and four weeks post-
intervention. However, the ANCOVA-adjusted between-
group differences in the mean pain scores for each of the
secondary pain outcomes were also not statistically signifi-
cant (Table 2).
Because we thought that any potential pain reductions
could be associated with reductions in plantar pressure, as
a result of the physical removal of the callus, we also
assessed whether there were differences in plantar pressure
between the two groups following the intervention. As
plantar pressure is affected by walking speed, we first
needed to assess whether walking speed differed between
the two groups at the three time-points. There were no dif-
ferences in walking speed between the two groups at pre-
intervention (F1-78 = 2.115, P = 0.150), immediately post-
intervention (F1-78 = 2.597, P = 0.111), and at six weeks
post-intervention (F1-78 = 2.815, P = 0.097). Once it was
ascertained that there was no difference in walking speed,
we then compared the mean difference in peak pressure
under the callus site between the two groups. There were
no significant differences in peak pressure immediately
post-intervention and at six weeks post-intervention
(Table 2).
In addition, we measured physical performance, as we
considered this might have been positively affected by
reducing pain associated with the plantar forefoot callus.
There were no significant differences in any of the bal-
ance or functional tests we performed (Table 2).
Assessed for eligibility (n=157)
Randomised (n=80)
Excluded (n=77)
Not meeting inclusion criteria – e.g. no
hyperkeratosis or insufficient pain (n=75)
Other reasons – insufficient English to
understand instructions (n=2)
Allocated to the intervention group – real scalpel
debridement (n=41)
Received allocated intervention (n=41)
Allocated to the control group – sham scalpel
debridement (n=39)
Received allocated intervention (n=39)
Lost to follow  up (n=1)
Used other interventions (n=0) Used other interventions (n=2)
Analysed (n=41) Analysed (n=39)
























Lost to follow  up (n=1)
Figure 1 Participant flow diagram.
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There were no adverse events in the real debridement
group, while two participants in the sham debridement
group experienced pain levels that led them to break the
trial protocol. One participant received treatment from a
podiatrist outside of the trial at four weeks post-
intervention and the other self-treated with a callus rasp
five weeks after the intervention was administered. Both
participants returned for the six-week follow-up appoint-
ment and final outcomes were measured.
Discussion
We found that, while both groups improved, there was no
statistically significant difference between real scalpel de-
bridement and sham scalpel debridement for reducing the
pain associated with forefoot plantar calluses in older people.
The technique used for the sham (control) intervention has
been used before [38] and involved the application of the
blunt edge of a scalpel blade to all of the forefoot plantar cal-
luses. This technique simulated real scalpel debridement
without physically removing any tissue. Therefore, the re-
duction in pain experienced by the sham debridement group
was most likely due to non-intervention effects, such as the
Hawthorne effect. This is an important point, and mayexplain, in part, the seemingly large improvements experi-
enced by patients receiving this intervention in clinical
practice.
Although none of the ANCOVA-adjusted between-
group differences were statistically significant, the un-
adjusted mean pain scores for both groups over the six-
week period (see Figure 2) highlight that immediately
post-intervention and for weeks one to four, the real de-
bridement group systematically had less pain than the
sham debridement group. The ANCOVA-adjusted dif-
ference in pain was of the order of 6 to 7 mm on a 100-
mm visual analogue scale. In our original sample size
calculation, we selected a value of 13 mm on a visual
analogue scale for pain as a clinically worthwhile value
to be able to detect, based on a range from the emer-
gency medicine literature of 9 to 13 mm [39-41]. There
are no specific reports of minimal important difference
values for the visual analogue scale for painful calluses
in older people. Nonetheless, we have calculated min-
imal important differences for plantar heel pain, which
we have estimated to be of the order of 8 to 9 mm on a
visual analogue scale [42]. With these values in mind,
the effect of real scalpel debridement alone on pain is
smaller than that considered clinically worthwhile.
Table 2 Mean (SD) outcome scores and ANCOVA-adjusted estimates of mean (95% confidence interval) differences
between groups
Outcome Outcome score ANCOVA-adjusted estimates of the effects
Real debridement Sham debridement Difference between groups t statistic P
(n = 41) (n = 39) (95% confidence interval)a
Primary outcome:
Reduction in pain (mm on a visual analogue scale)
Baseline 54.6 (21.0) 47.3 (20.8)
Immediately post-intervention 16.0 (16.4) 19.7 (19.1) −6.0 (−13.6 to 1.7) −1.555 0.124
1-week post-intervention 12.7 (12.9) 19.1 (23.4) −7.2 (−15.6 to 1.3) −1.685 0.096
3-weeks post-intervention 24.8 (20.0) 29.4 (26.7) −6.3 (−16.7 to 4.1) −1.213 0.229
6-weeks post-intervention 38.7 (31.4) 36.7 (30.6) −2.2 (−15.0 to 10.5) −0.347 0.730
Secondary outcomes:
Reduction in pain (mm on a visual analogue scale)
Baseline 54.6 (21.0) 47.3 (20.8)
2-weeks post-intervention 16.9 (16.4) 23.0 (21.0) −7.0 (−15.4 to 1.4) −1.651 0.103
4-weeks post-intervention 31.4 (24.1) 35.8 (29.0) −6.8 (−18.3 to 4.8) −1.166 0.247
5-weeks post-intervention 40.7 (28.9) 38.1 (31.1) −0.4 (−13.3 to 12.6) −0.059 0.953
Peak plantar pressure (kg/cm2)
Baseline 2.2 (0.5) 2.4 (0.4)
Immediately post-intervention 2.2 (0.5) 2.4 (0.4) 0.0 (−0.1 to 0.0) −1.091 0.279
6-weeks post-intervention 2.2 (0.5) 2.4 (0.4) 0.0 (−0.1 to 0.1) 0.106 0.916
Physical performance:
Maximum balance range (cm)
Baseline 12.0 (4.1) 11.1 (2.8)
Immediately post-intervention 12.3 (3.4) 11.5 (3.6) 0.0 (−0.8 to 0.9) 0.082 0.935
6-weeks post-intervention 12.5 (3.4) 11.9 (2.8) 0.0 (−0.9 to 0.9) −0.095 0.924
Timed sit-to-stand test (s)
Baseline 14.2 (4.6) 14.5 (4.6)
Immediately post-intervention 13.1 (3.7) 12.9 (3.5) 0.3 (−0.6 to 1.3) 0.725 0.470
6-weeks post-intervention 12.7 (3.0) 12.6 (3.5) 0.2 (−0.8 to 1.3) 0.475 0.636
Timed alternate step test (s)
Baseline 13.7 (4.4) 13.5 (3.8)
Immediately post-intervention 12.4 (2.9) 12.4 (2.9) −0.2 (−0.9 to 0.5) −0.659 0.512
6-weeks post-intervention 12.4 (3.1) 12.4 (3.4) −0.1 (−1.1 to 0.8) −0.248 0.805
6-m walking test (s)
Baseline 6.1 (1.6) 6.7 (1.6)
Immediately post-intervention 5.7 (1.3) 6.1 (1.3) −0.1 (−0.3 to 0.1) −0.687 0.494
6-weeks post-intervention 5.8 (1.3) 6.3 (1.6) −0.1 (−0.5 to 0.2) −0.821 0.414
aA negative result favors the experimental group and a positive result favors the control group.
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research is difficult because the only other random-
ized trial comparing normal scalpel debridement with
sham scalpel debridement of painful plantar calluses,
by Davys and colleagues [38], was conducted in
people with rheumatoid arthritis. In this trial, bothgroups reported a minimal reduction in pain (that is
3 mm on a 100-mm visual analogue scale) immedi-
ately post-intervention; the between-group difference
was not statistically significant. However, these results
cannot be generalized to people without rheumatoid arth-


























Figure 2 Comparison of pain scores over time between the real debridement group and the sham debridement group. Values are
means (SD).
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fectiveness of callus debridement.
Nonetheless, two non-randomized trials have evaluated
the effectiveness of scalpel debridement of plantar calluses
for reducing pain in people without inflammatory arthritis
[19,21]. One case series, consisting of 79 participants,
reported a statistically significant median difference of 59.5
mm (on a 100-mm visual analogue scale), an 86% reduc-
tion, between pre- and immediately post-intervention pain
scores (P < 0.001) [19]. This trial included both younger
and older people (ranging from 21 to 90 years). Another
study, conducted on 19 older people (aged between 65 and
84 years), found a statistically significant mean pain reduc-
tion of 68% (or 25 mm) immediately after scalpel debride-
ment (P < 0.001) [21]. In our trial, the mean pain
improvement immediately post-intervention in the real de-
bridement group reflects a 68% (or 38 mm) reduction on a
100 mm visual analogue scale. However, the sham debride-
ment group also experienced a 55% (or 26 mm) pain reduc-
tion. Therefore, the overall pain reduction observed for
scalpel debridement in our trial is consistent with the previ-
ous non-randomized trials, but a substantial amount of the
reduction could have been due to confounding non-
intervention effects, which are not accounted for in non-
randomized trials. Inclusion of a control group to compare
the intervention against is clearly important in determining
the true effect of an intervention.
We also found that real scalpel debridement had no
significant influence on plantar pressure under the fore-
foot or on physical performance. Changes in plantarpressure have been measured previously in a study of 15
participants (7 men and 8 women, mean age 67) with
plantar callus [43]. As in our trial, it was found that de-
bridement did not significantly alter peak plantar pres-
sure. With regard to function, a previous case series
found that callus debridement did have a beneficial sig-
nificant effect on functional ability [21]. However, be-
cause this study did not include a comparison group,
much of the effect observed could have been due to
non-intervention effects.
Few adverse events were observed in our trial. No ad-
verse events were experienced in the real debridement
group, while two participants in the sham debridement
group experienced pain levels that led them to break the
trial protocol. Accordingly, scalpel debridement adminis-
tered under appropriate conditions for painful plantar
calluses in older people leads to minimal adverse effects.
Furthermore, scalpel debridement is a relatively inexpen-
sive intervention. So, it can be concluded that scalpel de-
bridement of painful plantar calluses in older people is
inexpensive and causes few complications, but only pro-
vides small reductions in pain when used on its own.
This trial needs to be considered in light of four limita-
tions. First, the mean time taken to debride the plantar
forefoot calluses in the experimental group was almost
three minutes longer than in the control group (13.9 mi-
nutes versus 11.0 minutes). However, it can be argued that
this difference did not have an undue effect, as the differ-
ence is relatively small. Second, the investigators that pro-
vided the treatment to the participants were podiatry
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perienced podiatrist might have potentially debrided the
callus further (during real debridement), which could have
influenced the symptoms experienced by participants in the
experimental group. However, the students had between 3
and 4 years of callus debridement experience, constituting
between 800 and 1000 hours of clinical experience. More-
over, the change in pain in our trial was similar to previous
trials that used experienced clinicians, indicating that clin-
ical experience did not affect the generalizability of our
findings [19,21]. Third, scalpel debridement was evaluated
in isolation over a relatively short period (6 weeks), so our
findings do not preclude the possibility of additive effects
when combined with other interventions (such as foot orth-
oses) or cumulative benefits over a longer period. Finally,
our intervention period was only 6 weeks, which is at the
lower end of the range for time between debridement for
calluses in clinical practice. In Australia, common return
periods for callus debridement range between 6 and 8
weeks, although in the National Health Service in the
United Kingdom, this can be longer [44]. From our results,
it is unknown what effect a longer period of time between
treatments would have on the outcomes that we measured.
Consequently, the generalizability of our results, where we
measured the effect over a 6-week period, might be limited
when compared to longer periods between treatments.
Our trial also has a number of strengths. The results
can be generalized to the wider population of community-
dwelling older people seeking treatment for painful plan-
tar calluses, and we used a common treatment method
that reflected standard clinical practice. Moreover, the in-
ternal validity of our trial is assured by the rigorous meth-
odological procedures used to obtain the results, such as
allocation concealment, a sham debridement control
group, participant and assessor blinding, minimal missing
data, and intention-to-treat analysis.Conclusions
Our trial found that the benefits of real scalpel debride-
ment for reducing pain associated with forefoot plantar
calluses in older people are small and not statistically
significant compared with sham scalpel debridement.
When used alone, scalpel debridement is not clinically
worthwhile in the short term. However, these findings
do not preclude the possibility of cumulative benefits
over a longer time period or additive effects when com-
bined with other interventions.
Abbreviations
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